Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Others
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Abs. 8 Sgb V Zum Wirkstoff Lipegfilgrastim, (obo) Atc L03aa14 Für Die Zeit 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Others
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Abs. 8 Sgb V Zum Wirkstoff Aripiprazol (ausschl. Dafo Zur Herstellung Einer Dis), (obo) Atc N05ax12 Für Die Zeit 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Others
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Abs. 8 Sgb V Zum Wirkstoff Baricitinib, (obo) Atc L04aa37 Für Die Zeit 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Abs. 8 Sgb V Zum Wirkstoff Perindopril U. Indapamid (ausschl. Perindopril Als Arginin-salz), Atc C09ba54 F. D. Z. 01.02.25 - 31.01.27
Closing Date4 Dec 2026
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient baricitinib, (obo) ATC L04aa37 for the period 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Others
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient mepolizumab, (obo) ATC R03dx09 for the period 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Others
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient ranolazine, (obg) ATC C01eb18 for the period 01.02.2025 - 31.03.2025
Closing Soon5 Feb 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient flupentixol, (obg) ATC N05af01 for the period 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code V for the active ingredient lipegfilgrastim, (obo) ATC L03aa14 for the period 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active ingredient aripiprazole (excl. Dafo for the preparation of a DIS), (obo) ATC N05ax12 for the period 01.02.2025 - 31.01.2027
Closing Date4 Dec 2026
Tender AmountRefer Documents 
21-30 of 337 active Tenders